Free Trial

Kevin Fischbeck Analyst Performance

Analyst at Bank of America

Kevin Fischbeck is a stock analyst at Bank of America in the medical sector, covering 14 publicly traded companies. Over the past year, Kevin Fischbeck has issued 17 stock ratings, including buy, hold, and sell recommendations. While full access to Kevin Fischbeck's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kevin Fischbeck's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
31 Last 11 Years
Buy Recommendations
38.71% 12 Buy Ratings
Companies Covered
14 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy38.7%12 ratings
Hold32.3%10 ratings
Sell29.0%9 ratings

Out of 31 total stock ratings issued by Kevin Fischbeck at Bank of America, the majority (38.7%) have been Buy recommendations, followed by 32.3% Hold and 29.0% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
92.9% of companies on NYSE
13 companies
NASDAQ
7.1% of companies on NASDAQ
1 company

Kevin Fischbeck, an analyst at Bank of America, currently covers 14 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
14 companies
100.0%

Kevin Fischbeck of Bank of America specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - HOSPITALS
5 companies
35.7%
MEDICAL SERVICES
3 companies
21.4%
MED - HMO
3 companies
21.4%
MED - OUTP/HM CRE
2 companies
14.3%
HOSPITAL & MEDICAL SERVICE PLANS
1 company
7.1%

Kevin Fischbeck's Ratings History at Bank of America

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
9/10/2025Boost Price Target$192.54$225.00Buy
Encompass Health Corporation stock logo
EHC
Encompass Health
9/10/2025Boost Price Target$123.90$160.00Buy
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
9/10/2025Lower Price Target$19.84$18.00Underperform
DaVita Inc. stock logo
DVA
DaVita
9/10/2025Lower Price Target$134.35$140.00Underperform
Humana Inc. stock logo
HUM
Humana
9/2/2025Boost Price Target$313.94$312.00Neutral
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
8/18/2025Boost Price Target$304.02$325.00Neutral
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
7/29/2025Lower Price Target$264.18$300.00Neutral
Ardent Health, Inc. stock logo
ARDT
Ardent Health
7/16/2025Downgrade$13.93$14.60Underperform
Centene Corporation stock logo
CNC
Centene
7/16/2025Downgrade$30.00$30.00Underperform
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
7/16/2025Downgrade$371.69$394.00Neutral
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
7/16/2025Downgrade$176.91$185.00Underperform
Centene Corporation stock logo
CNC
Centene
7/2/2025Lower Price Target$37.48$52.00Neutral
Humana Inc. stock logo
HUM
Humana
6/17/2025Lower Price Target$239.20$260.00Neutral
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
5/14/2025Downgrade$320.99$350.00Neutral
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
5/14/2025Boost Price Target$159.71$180.00Buy
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
2/28/2025Lower Price Target$40.26$44.50Buy
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
1/27/2025Lower Price Target$329.30$370.00Buy